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Abstract
The structural manipulation of small molecule metabolites occurs in all organisms and plays a 
fundamental role in essentially all biological processes. Despite an increasing interest in 
developing new, non-enzymatic chemical reactions capable of functioning in the presence of 
living organisms, the ability of such transformations to interface with cellular metabolism and 
influence biological function is a comparatively underexplored area of research. This review will 
discuss efforts to combine non-enzymatic chemistry with microbial metabolism. We will highlight 
recent and historical uses of non-biological reactions to study microbial growth and function, the 
use of non-enzymatic transformations to rescue auxotrophic microorganisms, and the combination 
of engineered microbial metabolism and biocompatible chemical reactions for organic synthesis.
1.1 Introduction
Microorganisms are the most abundant and diverse organisms on Earth. Through billions of 
years of evolution they have acquired the ability to inhabit an astonishing array of 
environments [1]. These include the extreme temperatures found in deep-sea hydrothermal 
vents (hyperthermophiles) [2] and in subterranean ice sheets (psychrophiles) [3]; the high 
pressure of the Mariana Trench (piezophiles) [4]; and various sites in and on the human 
body (the human microbiota) [5]. To support growth in these habitats, many microbes have 
coevolved strategies to support their metabolism that involve chemistry not encoded by their 
genomes. In many cases survival is therefore dependent on a microbe’s ability to interface 
its metabolism with the surrounding chemical environment. Conceptually this parallels the 
way synthetic chemists make molecules in a laboratory setting, using non-enzymatic 
reagents and catalysts to synthesize molecules essential to our everyday lives.
Over the last several decades there has been a steadily growing interest in developing non-
biological chemical transformations for use in a cellular setting [6–12]. Although such 
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reactions have been demonstrated to occur in both cells and in living organisms and are 
powerful tools for studying natural biological processes (bioorthogonal chemistry), the 
question of whether or not their reactivity can interface with cellular metabolism and alter 
biological function remains comparatively underexplored. One approach to achieving this 
goal is the development of biocompatible chemistry: non-enzymatic reactions that alter the 
structures of metabolites as they are produced by living organisms. There are multiple ways 
in which biocompatible transformations could be integrated with cellular metabolism 
(Figure 1). They could modify the end products of metabolic pathways, support metabolic 
functions by generating key substrates or nutrients in vivo, or be fully integrated into cellular 
metabolism.
One of the largest challenges encountered in merging non-enzymatic chemistry with 
metabolism is the apparent mismatch between the approaches used in synthetic organic 
chemistry (non-aqueous solvents, rare earth and transition metals, reactive intermediates, 
extreme temperatures and pH) and the growth conditions required to support a living 
organism (aqueous media, ambient temperature, neutral pH). The complexity of the cellular 
and extracellular environments and the typically low concentrations of cellular metabolites 
are also potential concerns. As has been the case with bioorthogonal reactions, we feel that 
these obstacles may be overcome through reaction screening optimization and that the 
potential benefits associated with the realization of this approach justify the challenges 
associated with developing such transformations.
Biocompatible chemistry would provide scientists with a unique toolkit for manipulating 
and augmenting biological function in vivo that would not require genetic manipulation and 
could be applied to both cultured and uncultured organisms. This review will discuss recent 
achievements in combining non-enzymatic chemistry with metabolism, with a particular 
emphasis on studies involving microorganisms. We will focus on non-enzymatic reactions 
that have a direct influence on metabolic function. We will not include examples that use 
solely genetic approaches to manipulate metabolism or studies that use non-enzymatic de-
caging strategies to control protein function in vivo. We will highlight key experiments that 
have seeded interest in this topic and provide our perspective on the future challenges and 
opportunities for this area of research.
2.1 The role of non-enzymatic chemistry in natural microbial habitats
Before discussing examples of non-biological transformations that have been designed by 
chemists and chemical biologists to function in the presence of living systems, we will 
briefly discuss several examples of how microbes have evolved to utilize non-enzymatic 
reactions to facilitate growth in natural settings. The influence of non-enzymatic chemistry 
on microbial metabolism is a phenomenon often observed in natural microbial populations. 
Non-enzymatic transformations have also frequently been proposed to play important roles 
in the origin of life and metabolic pathways. In 1924 biochemist Aleksandr Oparin first 
hypothesized that carbon-based metabolism could have originated from non-enzymatic 
chemistry enabled by the highly reducing geochemical environment of the early Earth [13–
16]. In support of this hypothesis, ferrous iron has been shown to catalyze transformations 
that in modern organisms constitute glycolysis and pentose phosphate pathway chemistry, 
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suggesting that the origins of cellular metabolism could date back to non-enzymatic 
chemistry operating in the iron-rich oceans of the prebiotic world [17].
The chemistry of environmental iron impacts microbial survival in limiting habitats [18–22]. 
Under oxygen-limiting conditions many facultative anaerobic microbes use extracellular 
iron and manganese ions as terminal electron acceptors [23]. This use of redox-active 
environmental metals is especially remarkable due to the chemical challenges associated 
with their acquisition. For example, geological manganese and iron exist in metal oxides/
oxyhydroxides that are inaccessible to reduction due to their insolubility. Microbes 
overcome this issue by excreting small molecules capable of solubilizing these metal ions 
(siderophores), as well as redox active small molecules that can directly reduce metal oxides 
(extracellular electron shuttles) [24]. An example of a microbe that uses redox-active small 
molecules to facilitate respiration of metals is the opportunistic pathogen Pseudomonas 
aeruginosa, which secretes redox-active pigments collectively known as phenazines [25]. 
Secreted, reduced phenazines support respiration under anaerobic conditions by transferring 
electrons to nearby extracellular oxidants (frequently Fe2+/3+). This generates ATP through 
the Entner-Doudoroff pathway, which involves the non-enzymatic regeneration of NAD+ 
from accumulating NADH (Figure 2A) [26]. Phenazines and Fe2+ have been detected in the 
sputum of cystic fibrosis patients at levels consistent with this process supporting the 
anaerobic survival of P. aeruginosa in this environment and contributing to chronic 
infection [27,28]. This observation has led to research into iron-chelation therapy as a 
treatment for persistent P. aeruginosa infections [29–31].
Microbes in soil and aquatic ecosystems also use iron to support their metabolism by 
harnessing its reactivity to promote the non-enzymatic degradation of lignin [32]. Lignin is 
complex polymer containing aromatic functionality and is a critical component of plant cell 
walls. It represents one of the largest sources of fixed carbon on Earth and its biodegradation 
therefore occupies a significant role in global carbon cycling [33]. The white and brown rot 
fungi Perenniporia medulla-panis and Gloeophyllum trabeum degrade lignin to humic acids 
using an extracellular hydroquinone-quinone redox couple to environmental Fe3+ to produce 
hydrogen peroxide from oxygen [34]. This enables the non-enzymatic degradation of lignin 
via the generation of highly reactive hydroxyl radicals using Fenton chemistry (Figure 2B). 
In this context both G. trabeum and P. medulla-panis use non-enzymatic redox chemistry as 
a strategy to replace the function of lignin peroxidase, the enzyme used by other microbes to 
degrade lignin. The humic acids released in this process serve as a primary source of carbon 
and as terminal electron acceptors for a variety of organisms in nutrient and oxygen-poor 
soil and aquatic environments.
3.1 Developing non-enzymatic chemistry to control biological function
The ability of chemists to develop chemical reactions that extend beyond what is available 
to living organisms in natural environments opens up the possibility of developing new ways 
of linking microbial metabolism to non-enzymatic chemistry. Specifically, biocompatible 
non-enzymatic chemistry could enable the chemical manipulation of small organic 
molecules such as cofactors and metabolites in ways that could impact cellular function. 
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Indeed, chemists have achieved this goal by harnessing the reactivity of both stoichiometric 
small organic reagents and transition metal catalysts.
Much of the seminal work in this area has focused on using non-enzymatic redox chemistry 
to manipulate the redox state of cellular components. In 1969, Kosower reported the 
stoichiometric use of the organic reagent diamide to oxidize the endogenous antioxidant 
glutathione (GSH) to glutathione disulfide (GSSG) in vivo in E. coli. (Figure 3A) [35]. In 
addition to detoxifying reactive oxygen species and free radicals in the cell, GSH also serves 
as a cofactor for enzymes that mediate redox chemistry. Under normal cellular conditions 
over 90% of GSH is in its reduced form. In vivo manipulation of GSH and GSSG levels 
impacts a variety of cellular functions, especially in cells recovering from oxidative damage. 
In 2014, Ward and coworkers also employed stoichiometric diamide to oxidize the GSH 
present in E. coli cell lysates, improving the efficiency of transition metal mediated reactions 
in this environment [36]. Oxidation of GSH in vivo has also been accomplished using 
transitional metal complexes (Figure 3B). Sadler and coworkers have shown the ruthenium 
piano-stool complexes efficiently oxidize GSH to GSSG without issues of poisoning for 
living human ovarian and lung cancer cell lines [37]. The same group has also reported an 
iridium-catalyzed transfer-hydrogenation that can operate in vivo to modulate redox balance 
in cells by converting the co-factor NADH to NAD+ and hydrogen [38]. The non-enzymatic 
oxidation of NADH has the potential to impact the functions of enzymes that use this redox 
cofactor and may enhance or reduce growth depending on an organism’s mode of 
metabolism. Such catalysts could also potentially alter redox balance in ways that could be 
beneficial in the context of engineered metabolic pathways.
While the chemistry mentioned above affects the homeostasis of organisms by oxidizing 
cellular reductants, researchers have also been interested in developing catalytic anti-
oxidants to reduce the strain placed on organisms and cells by excess reactive oxygen 
species [39]. The most prevalent catalytic antioxidants are manganese(II) porphyrin 
complexes that mimic the activity of superoxide dismutase (SOD), reducing superoxide, 
peroxynitrite, carbonate anion radical, hypochlorite, nitric oxide, lipid peroxyl radicals, and 
alkoxyl radicals, all of which can cause oxidative stress to cells [40]. There has been 
substantial interest in developing SOD mimics as pharmaceuticals, prompting many efforts 
to understand the in vivo activities of metalloporphyrins. SOD-deficient E. coli mutants have 
proven to be useful tools for investigating the minimal requirements of a functional SOD 
mimic [41]. Mutants lacking SOD enzymes exhibit growth defects in certain minimal media 
and restoration of growth is indicative of antioxidant activity. This system has enabled the 
efficient identification of catalytic antioxidants with high activity, low toxicity, and efficient 
cellular uptake.
Biocompatible chemistry can also be used to generate metabolites that play essential roles in 
metabolism. A recent study from our own laboratory has demonstrated the possibility of 
controlling microbial growth using non-enzymatic reactions (Figure 3C) [42]. In this report 
we were able to support the growth of multiple p-aminobenzoic acid auxotrophs via the 
[Cp*Ru(cod)Cl]-catalyzed deprotection of N-alloc-PABA in situ. Similarly, we used an 
iron-mediated hydroxylation reaction to rescue the growth of a p-hydroxybenzoic acid 
auxotroph. In both cases, the growth of the auxotrophic organism was dependent upon the 
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success of the non-enzymatic reaction. Rescued cultures retained their auxotrophies upon re-
inoculation into media lacking key nutrients, indicating that rescue was not the result of 
genetic changes in the organism over the course of the experiment. The product yields 
and/or isomer distributions were low for both reactions, highlighting how minor 
modulations of metabolite levels in a cell can have a dramatic impact on growth and 
function. Both of these transformations rescue auxotrophy by providing alternate routes to 
essential compounds and not by directly mimicking the missing biochemical function. The 
development of biocompatible catalysts that can replace the function of an essential 
metabolic enzyme is an important future goal that could also represent a new strategy for 
treating metabolic disorders.
4.1 Combining microbial metabolism and non-enzymatic chemistry for 
small molecule production
In addition to influencing core biological functions, the merging of biocompatible chemistry 
with microbial metabolism provides an opportunity to modify metabolites in ways that 
benefit efforts to utilize these organisms for chemical production. Advances in the field of 
synthetic biology have enabled the use of engineered microbes for the production of small 
molecules such as pharmaceuticals and commodity chemicals. Despite these achievements, 
many important chemical scaffolds cannot be accessed using this approach due to the 
differences in the scope of reactivity available to enzymes in comparison with that available 
to non-enzymatic catalysts and reagents [43]. A possible solution to this problem could 
involve combining biocompatible reactions with engineered metabolism for small molecule 
synthesis, a strategy that has been relatively underexplored [44]. To the best of our 
knowledge, the cooperative use of non-enzymatic chemistry from organic synthesis and 
microbial metabolism originated with Neuberg’s bisulfite-steered glycerol fermentations 
during the First World War [45,46]. Neuberg observed substantial overproduction of 
glycerol from glucose by Saccharomyces cerevisiae when sodium bisulfite was added to the 
fermentation. It was later discovered that the bisulfite anion formed a stable adduct with 
acetaldehyde, a metabolite generated en route to ethanol, the typical fermentation end 
product. Bisulfite adducts are used in organic chemistry as a method for protecting 
aldehydes [47]. This non-enzymatic reaction interfered with the reduction of acetaldehyde to 
ethanol, forcing accumulating NADH to be reoxidized to NAD+ via an alternate pathway, 
the reduction of dihydroxyacetone phosphate, which yielded glycerol as the primary 
product. This process contributed significantly to the German war effort by allowing the 
manufacture of glycerol from sugar for use in the production of explosives.
Our lab is developing new biocompatible chemical transformations that can be combined 
with microbial metabolism to enable chemical production. We have begun this work by 
identifying transition metal mediated reactions that can use metabolites generated in situ by 
living bacteria. Our initial studies focused on transformations that could engage the 
diffusible microbial metabolite hydrogen gas. Bacterially-produced hydrogen had previously 
been utilized for non-enzymatic chemistry on an analytical scale. Mountfort and co-workers 
demonstrated the use of hydrogenation chemistry to decouple the metabolism of the proton-
reducing syntrophic bacterium from a partner methanogen (Figure 4A) [48]. The syntrophic 
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bacterium Syntrophomonas wolfei and the methanogen Metanospirillum hungatei co-exist in 
an obligate metabolic partnership that couples the thermodynamically unfavorable oxidation 
of butyrate to acetate (acetogenesis) to the thermodynamically favorable production of 
methane from CO2 (methanogenesis) via the interspecies exchange of hydrogen. Culturing 
these organisms in the presence of ethylene gas and super-stoichiometric amounts of Pd-
BaSO4 resulted in the formation of ethane. This observation indicated that in the absence of 
a partner methanogen, S. wolfei was able to couple butyrate oxidation and hydrogen 
production to the reduction of ethylene by the palladium catalyst. This study demonstrated 
for the first time that it is possible to decouple the metabolic functions of two obligate 
syntrophs using a non-enzymatic transition metal catalyzed hydrogenation.
Inspired by this observation, our laboratory recently reported a biocompatible alkene 
hydrogenation reaction that utilizes hydrogen generated by living bacteria (Figure 4B) [49]. 
We used a strain of E. coli engineered to produce hydrogen via a single inducible pathway 
consisting of a pyruvate ferredoxin oxidoreductase, a ferredoxin, and a [Fe–Fe] hydrogenase 
(Figure 4C). After demonstrating that heterogeneous transition metal catalysts could 
promote alkene hydrogenation in growth media using bacterially-generated hydrogen, 
screening identified the Royer palladium catalyst (palladium on polyethyleneimine/SiO2) as 
an optimal hydrogenation catalyst. After further optimization, we identified conditions that 
could be applied to a range of alkene substrates and could be utilized for gram scale 
reactions. Growth of the hydrogen-producing E. coli cells was unaffected by the reaction 
components. To the best of our knowledge, this is the first time that the metabolic output of 
a living organism and a non-enzymatic chemical transformation have been directly 
combined for preparative scale chemical synthesis. Intended to compliment synthetic 
biology efforts, this study represents a crucial first step towards integrating biocompatible 
reactions with cellular metabolism for small molecule synthesis.
5.1 Outlook
The specific examples summarized here demonstrate the ability of non-enzymatic, 
biocompatible transformations to influence the metabolism of microorganisms. We believe 
that the timing is right for an expansion of this approach due to recent advances in organic 
chemistry and microbiology. Although discovering and optimizing biocompatible reactions 
poses technical challenges, many of these are conceptually identical to the obstacles faced 
by synthetic chemists in developing new reactions. Biocompatible chemistry may therefore 
take advantage of new, high-throughput approaches to reaction discovery that have been 
implemented by organic chemists [50–53]. Additionally, organic chemists are continuously 
developing mild bond-forming methods that operate under ambient and aqueous reaction 
conditions [54]. Access to increasingly powerful tools for synthesizing and assembling DNA 
has also made it possible to manipulate microbial metabolic pathways in new ways with 
unprecedented efficiency [55]. Microbial genome sequencing efforts are also rapidly 
expanding the ‘toolkit’ of enzymes available for metabolic engineering [56–59]. These 
advances will continue to expand the range of metabolites that can be accessed using 
microbial metabolism and interfaced with non-enzymatic chemistry, as well as enhance the 
speed with which such processes are developed.
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What are the most exciting potential future applications of interfaced chemistry and 
metabolism? In the context of chemical production, interfacing biocompatible reactions with 
the products of engineered microbial metabolism could rapidly diversify the structures of 
metabolites. The ability to access a range of potentially new chemical scaffolds directly 
from fermentations could change the way engineered organisms are used for chemical 
production, making microbial metabolism a useful source of new molecular scaffolds that 
could be evaluated for desired properties in addition to providing a route to chemicals of 
established importance. Engineered microbial metabolism could also be used to generate 
unstable, toxic, or inefficiently manufactured reagents directly in reaction mixtures, 
obviating the need to transport and store large quantities of these materials. Before this goal 
can be realized, biocompatible reactions must be optimized for process scale applications 
with regards to cost and efficiency.
Non-enzymatic reactions that can influence cellular metabolism may also have applications 
in microbiology and medicine. One can envision developing biocompatible reactions that 
modify the structures of metabolites exchanged in microbial communities. Transformations 
of this type could potentially alter community structure by disrupting cell-cell 
communication (quorum sensing) or manipulating metabolite exchange. This technology 
could be applied to reduce the susceptibility of communities like the human gut microbiota 
to dysbiosis or to invasion by pathogens. Reactions that interface with microbial metabolites 
could also perhaps aid in efforts to grow previously unculturable microbes by replacing 
essential metabolic interactions. Thinking beyond microorganisms, the development of 
biocompatible transformations that can directly replace the functions of metabolic enzymes 
could provide a new approach to treating human disease, particularly metabolic disorders 
that arise from deficiencies in enzyme function. Exploring both of these applications will 
require the identification of new catalysts that are not only functional and biocompatible, but 
also possess improved efficiency and selectivity.
6.1 Conclusion
The use of non-enzymatic, biocompatible reactions represents a new way to utilize, 
manipulate, and complement microbial metabolism. Small molecules synthesized by living 
organisms participate in and control an array of biological processes, making biocompatible 
chemistry a potentially powerful approach to influencing cellular function. Recent work has 
shown that reaction discovery and optimization efforts similar to those used in synthetic 
organic chemistry can access non-enzymatic transformations that function cooperatively 
with the metabolism of a living organism. We hope that these studies inspire future efforts to 
develop further transformations the can be utilized in this way, as well as new applications 
of natural and engineered metabolism in chemical manufacturing.
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Highlights
• Microorganisms have evolved to utilize non-enzymatic reactions to facilitate 
their survival in many environments.
• Non-enzymatic reactions developed by chemists can be interfaced with 
microbial metabolism and can have an influence on biological function.
• The products of engineered metabolism can be combined with non-enzymatic 
reactions to enable chemical synthesis.
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Figure 1. 
Approaches to interfacing biocompatible chemistry with microbial metabolism and potential 
applications of this technology.
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Figure 2. 
Non-enzymatic transformations that influence the survival of environmental microbes. A. 
Extracellular reduction of iron(II) by secreted phenazines enables the survival of 
Pseudomonas aeruginosa. B. Extracellular iron reduction by secreted quinones facilitates 
lignin degradation by fungi.
Wallace et al. Page 13
Curr Opin Chem Biol. Author manuscript; available in PMC 2016 April 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 3. 
Examples of non-enzymatic chemistry with the potential to control biological functions. A. 
Diamide can be used to oxidize glutathione in living organisms, altering intracellular redox 
chemistry and compromising cell membrane integrity. B. Ru-catalyzed oxidation of 
glutathione and Ir-catalyzed generation of oxidized nicotinamide via transfer hydrogenation. 
C. Generation of the essential metabolite (PABA) using a Ru-catalyzed alloc-deprotection 
reaction enables the growth of auxotrophic strains of E. coli.
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Figure 4. 
Chemical synthesis using biocompatible chemistry and microbial metabolism. A. A non-
enzymatic hydrogenation reaction can decouple microbial syntrophy. Acetogenesis by S. 
wolfei in the absence of interspecies hydrogen transfer is observed with the addition of 
ethylene and a heterogeneous palladium catalyst. B. Hydrogen produced by engineered E. 
coli can engage in non-enzymatic alkene reduction reactions using the Royer palladium 
catalyst. C. The engineered metabolic pathway in E. coli DD2 responsible for H2 production 
from D-glucose. Royer palladiums catalyst = 2.44% palladium on polyethyleneimine (PEI)/
silica gel.
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